Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.36 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | LAP3 | P28838 | 2/20 | 0.32 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5157972 | 0.85 | TDP1 (0.48) | TDP1SMN1; SMN2SLC22A6FOLH1ALOX15 | |
| SCHEMBL10212 | 0.80 | TDP1 (0.43) | TDP1SMN1; SMN2SLC22A6FOLH1ALOX15 | |
| SCHEMBL2593546 | 0.80 | TDP1 (0.43) | TDP1SMN1; SMN2SLC22A6FOLH1ALOX15 | |
| SCHEMBL2580759 | 0.80 | TDP1 (0.43) | TDP1SMN1; SMN2SLC22A6FOLH1ALOX15 | |
| SCHEMBL11672388 | 0.78 | TDP1 (0.42) | TDP1SMN1; SMN2SLC22A6FOLH1ALOX15 | |
| SCHEMBL6742371 | 0.78 | TDP1 (0.42) | TDP1SMN1; SMN2SLC22A6FOLH1ALOX15 | |
| SCHEMBL6295978 | 0.77 | GABRP (0.46) | FOLH1 | |
| SCHEMBL11689315 | 0.76 | TDP1 (0.40) | TDP1SMN1; SMN2SLC22A6FOLH1GABRR1 | |
| SCHEMBL16407998 | 0.76 | PPARA (0.42) | TDP1SMN1; SMN2SLC22A6 | |
| SCHEMBL2185057 | 0.76 | PPARA (0.42) | TDP1SMN1; SMN2SLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100092407-A1 | TOOTH-BLEACHING MATERIAL AND METHOD OF BLEACHING TOOTH | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2010-04-15 | — | — | US | disclosed |
| EP-2130528-A1 | TOOTH-BLEACHING MATERIAL AND METHOD OF BLEACHING TOOTH | Mitsubishi Gas Chemical Company, Inc. (JP) | 2009-12-09 | — | — | EP | disclosed |
| US-6964787-B2 | Method and system for reducing microbial burden on a food product | ECOLAB INC. (US) | 2005-11-15 | — | — | US | disclosed |
| US-6927237-B2 | Two solvent antimicrobial compositions and methods employing them | ECOLAB INC. (US) | 2005-08-09 | — | — | US | disclosed |
| US-20050096245-A1 | Two solvent antimicrobial compositions and methods employing them | ECOLAB INC. (US) | 2005-05-05 | — | — | US | disclosed |
| US-20020192340-A1 | Method and system for reducing microbial burden on a food product | ECOLAB USA INC. | 2002-12-19 | — | — | US | disclosed |
| US-20020168422-A1 | Two solvent antimicrobial compositions and methods employing them | ECOLAB USA INC. | 2002-11-14 | — | — | US | disclosed |
| WO-2002060280-A2 | METHOD AND SYSTEM FOR REDUCING MICROBIAL BURDEN ON A FOOD PRODUCT BY APPLICATION OF ANTIMICROBIAL AGENT AND IRRADIATION TO THE FOOD PRODUCT | ECOLAB INC. (US) | 2002-08-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020168422-A1 | Two solvent antimicrobial compositions and methods employing them | TAS2R50, HDHD5, CEL | TDP1 4047/4885SMN1; SMN2 1216/4885SLC22A6 1199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.